Earnings per Share (EPS) (Basic): A company's net earnings or losses attributable to common shareholders per basic share basis.
Verrica Pharmaceuticals Inc. (VRCA) had Earnings per Share (EPS) (Basic) of $-0.62 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$5.86M |
|
$-13.15M |
|
$0.88M |
|
$4.98M |
|
$18.96M |
|
$-13.10M |
|
$-0.06M |
|
$-13.15M |
|
$-13.15M |
|
$-13.15M |
|
$-13.15M |
|
$-13.15M |
|
$-13.15M |
|
$-13.10M |
|
$-12.89M |
|
21.30M |
|
21.30M |
|
|
Earnings per Share (EPS) (Basic) |
$-0.62 |
$-0.62 |
|
| Balance Sheet Financials | |
$32.64M |
|
$0.18M |
|
$3.38M |
|
$36.02M |
|
$22.44M |
|
$0.79M |
|
$9.27M |
|
$31.71M |
|
$4.31M |
|
$4.31M |
|
$4.31M |
|
17.18M |
|
| Cash Flow Statement Financials | |
$-18.44M |
|
$0.00M |
|
$-0.25M |
|
$30.15M |
|
$11.46M |
|
$-18.69M |
|
$2.11M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.45 |
|
-- |
|
-- |
|
0.16 |
|
0.32 |
|
85.02% |
|
-223.42% |
|
-223.42% |
|
-- |
|
-224.38% |
|
-224.38% |
|
$-18.44M |
|
-- |
|
-- |
|
-- |
|
0.16 |
|
0.32 |
|
0.53 |
|
170.27 |
|
-305.38% |
|
-305.39% |
|
-36.52% |
|
-257.90% |
|
$0.25 |
|
$-0.87 |
|
$-0.87 |
|